Stay updated on Novel Therapeutics for High-Risk AML Clinical Trial
Sign up to get notified when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.

Latest updates to the Novel Therapeutics for High-Risk AML Clinical Trial page
- ChecktodayChange DetectedNew history entries dated 2025-12-15 add Contacts/Locations and Study Status, with corresponding version entries 149–153 from 2025-12-06 to 2025-12-15, and a deletion on 2025-12-04.SummaryDifference0.5%

- Check8 days agoChange DetectedNew history entries were added on 2025-12-04 (version 148) to include Contacts/Locations and Study Status, with an earlier addition on 2025-12-02 (version 147). A deletion entry dated 2025-11-28 is also shown in the history.SummaryDifference0.2%

- Check15 days agoChange DetectedRecord History now includes new entries for Contacts/Locations and Study Status, with added version numbers (145 and 146), and a deletion on 2025-11-24. These are structural history updates rather than substantive changes to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check22 days agoChange DetectedNew history entries on 2025-11-24 add Contacts/Locations and Study Status, along with Revision: v3.3.2. The prior Revision: v3.2.0 has been removed.SummaryDifference0.3%

- Check29 days agoChange DetectedAdded 2025-11-07 entry with Contacts/Locations and Study Status (version 142).SummaryDifference0.3%

- Check36 days agoChange DetectedNew history entries on 2025-11-04 and 2025-11-05 add updates to Study Status and Contacts/Locations (versions 140 and 141). These updates reflect the current administrative details of the trial.SummaryDifference0.3%

Stay in the know with updates to Novel Therapeutics for High-Risk AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Novel Therapeutics for High-Risk AML Clinical Trial page.